Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial)

New article on Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection from the Journal of Hospital Infection

#vascularaccess #FOAMva #FOAMed #infectionprevention #patientsafety

CVC care in pediatric onco-hematology January 27, 2022
"Management and successful use of vascular access are critical issues in pediatric patients affected by malignancies" Crocoli et al (2022).
IVTEAM
Cefepime prolonged infusions January 27, 2022
"No difference in risk of ADEs including AKI was seen with cefepime PI in pediatric CF patients. Clinical outcomes were not significantly different between groups, but sample size may have limited comparison" Imburgia et al (2022).
IVTEAM
Treating extravasation injury with fish skin – Full Text January 27, 2022
"This case illustrates that tilapia fish skin may be a suitable alternative to other temporary skin cover dressings in premature newborns suffering from extravasation injury" Faraji et al (2022).
IVTEAM
CLABSI treatment with broad spectrum gram-negative antibiotics January 27, 2022
"Broader spectrum gram-negative antibiotics are commonly utilized empirically for central line-associated bloodstream infections (CLABSI) in febrile short bowel syndrome (SBS) patients receiving home parenteral nutrition compared to those used empirically for inpatient-acquired CLABSI" Stultz et al (2022).
IVTEAM
Administration of 3% NaCl in children January 27, 2022
"Only 32% of hospital pharmacies allowed 3% NaCl to be administered through a peripheral IV in a non-intensive care unit setting" Shah at al (2022).
IVTEAM

%d bloggers like this:

Share this:

Like this:

Related